Showing results (191-200 of 236) with videos related to
Sort By:
Pageof 24
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 4, 2025
Switching from anti-CD20 therapies to cladribine and vice versa - Analysis of a German relapsing multiple sclerosis cohortFranz Felix Konen, Steffen Pfeuffer, Konstantin Fritz Jendretzky, et al.Neurological Research and Practice|July 17, 2025
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritisFranz Felix Konen, Torsten Witte, Diana Ernst, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 25, 2021
Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune EncephalitisPhilipp Schwenkenbecher, Thomas Skripuletz, Peter Lange, et al.Experimental Neurology|July 27, 2018
Impairment of frequency-specific responses associated with altered electrical activity patterns in auditory thalamus following focal and general demyelinationVenu Narayanan, Manuela Cerina, Kerstin Göbel, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2015
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosisJonas Ahlbrecht, Filippo Martino, Refik Pul, et al.Autoimmunity Reviews|March 16, 2023
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.Journal of Neurology|June 12, 2025
Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse eventsLeonie Müller-Jensen, Nora Möhn, Thomas Skripuletz, et al.Annals of Clinical and Translational Neurology|July 10, 2025
Digital Activity Markers in Chronic Inflammatory Demyelinating PolyneuropathyLars Masanneck, Jan Voth, Noëmi Gmahl, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2025
Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosisPia Winter, Franziska Axhausen, Stephanie Wolff, et al.Brain, Behavior, and Immunity|August 30, 2016
The quality of cortical network function recovery depends on localization and degree of axonal demyelinationManuela Cerina, Venu Narayanan, Kerstin Göbel, et al.Pageof 24